Q4 2021 Holdings
Filed 2022-02-14 | 72 holdings | $196.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $67.2M | 499,824 | 34.2% |
| Abbvie Inc(ABBV) | COMM | 00287Y109 | $42.2M | 312,018 | 21.5% |
| Align Technology Inc(ALGN) | COMM | 016255101 | $25.1M | 38,159 | 12.8% |
| Cytokinetics Inc(CYTK) | COMM | 23282W605 | $21.2M | 464,366 | 10.8% |
| BioCryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $20.9M | 1,510,473 | 10.7% |
| Celldex Therapeutics Inc(CLDX) | COMM | 15117B202 | $10.5M | 271,533 | 5.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $7.7M | 87,322 | 3.9% |
| Natera Inc(NTRA) | COMM | 632307104 | $289.8K | 3,102,960 | 0.1% |
| Karuna Therapeutics Inc | COMM | 48576A100 | $255.9K | 1,953,077 | 0.1% |
| Vera Therapeutics, Inc.(VERA) | CL A | 92337R101 | $77.9K | 2,914,776 | 0.0% |
| Roche Holding AG(RHHBY) | ADR | 771195104 | $70.8K | 1,369,011 | 0.0% |
| Spdr S&P 500 ETF Trust(SPY)Put | COMM | 78462F103 | $47.5K | 100,000 | 0.0% |
| Aerovate Therapeutics, Inc. | COMM | 008064107 | $44.3K | 3,758,686 | 0.0% |
| Invesco QQQ Trust Series 1(QQQ)Put | COMM | 46090E103 | $39.8K | 100,000 | 0.0% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $35.6K | 2,194,278 | 0.0% |
| iShares Russell 2000 ETF(IWM)Put | COMM | 464287655 | $33.4K | 150,000 | 0.0% |
| Regenxbio Inc(RGNX) | COMM | 75901B107 | $33.0K | 1,008,081 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COMM | 89422G107 | $32.3K | 1,040,858 | 0.0% |
| United Therapeutics Corp(UTHR) | COMM | 91307C102 | $28.0K | 129,754 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COMM | 427746102 | $26.8K | 2,933,351 | 0.0% |
| ChemoCentryx Inc(CCXIEUR) | COMM | 16383L106 | $26.6K | 731,222 | 0.0% |
| Blueprint Medicines Corp(2L9) | COMM | 09627Y109 | $26.3K | 245,182 | 0.0% |
| Horizon Therapeutics PLC | COMM | G46188101 | $23.9K | 221,792 | 0.0% |
| Guardant Health Inc(GH) | COMM | 40131M109 | $23.3K | 232,563 | 0.0% |
| Xencor Inc(XNCR) | COMM | 98401F105 | $21.5K | 537,030 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COMM | 87164F105 | $20.8K | 951,226 | 0.0% |
| iRhythm Technologies Inc(IRTC) | COMM | 450056106 | $19.9K | 168,882 | 0.0% |
| Dexcom Inc(DXCM) | COMM | 252131107 | $17.4K | 32,404 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COMM | 74366E102 | $16.5K | 482,257 | 0.0% |
| Inhibrx Inc(INBXUSD) | COMM | 45720L107 | $16.1K | 368,679 | 0.0% |
| Nextcure, Inc | COMM | 65343E108 | $16.0K | 2,671,856 | 0.0% |
| Galera Therapeutics, Inc(GRTX) | COMM | 36338D108 | $14.2K | 3,083,712 | 0.0% |
| Inozyme Pharma, Inc. | COMM | 45790W108 | $13.8K | 2,028,308 | 0.0% |
| Immatics NV(IMTX) | COMM | N44445109 | $13.8K | 1,026,623 | 0.0% |
| Bolt Biotherapeutics, Inc.(BOLT1EUR) | COMM | 097702104 | $13.5K | 2,754,437 | 0.0% |
| Iveric Bio Inc(OPHTEUR) | COMM | 46583P102 | $13.4K | 798,789 | 0.0% |
| Nucana Plc | ADR | 67022C106 | $13.3K | 5,599,999 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COMM | 481116101 | $13.2K | 1,582,777 | 0.0% |
| ImmunoGen Inc(IMGNEUR) | COMM | 45253H101 | $13.0K | 1,749,882 | 0.0% |
| Akouos, Inc. | COMM | 00973J101 | $12.9K | 1,515,074 | 0.0% |
| Insmed Inc(INSM) | COMM | 457669307 | $12.0K | 441,773 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COMM | 359616109 | $10.9K | 617,670 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COMM | 803607100 | $10.9K | 120,732 | 0.0% |
| Checkmate Pharmaceuticals Inc | COMM | 162818108 | $10.4K | 3,606,707 | 0.0% |
| Protagonist Therapeutics Inc(PTGX)Call | COMM | 74366E102 | $10.3K | 300,600 | 0.0% |
| Uniqure NV(QURE) | COMM | N90064101 | $10.3K | 495,025 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $9.5K | 4,749,623 | 0.0% |
| Vir Biotechnology Inc(VIR)Put | COMM | 92764N102 | $8.4K | 200,000 | 0.0% |
| Zymeworks Inc | COMM | 98985W102 | $6.4K | 392,712 | 0.0% |
| Agenus Inc(AGENEUR) | COMM | 00847G705 | $6.3K | 1,961,032 | 0.0% |